Post by
beechguy on Aug 27, 2015 3:04pm
Friday or Monday
I think we will have a 4-6mm share day if priority review is granted. Then a significant hurdle has been removed and the likelihood of approval jumps exponentially. Will be disappointing if they go standard review or RTF tho not as big a deal as it would have been a week ago. Very intrigued to see what plans they have in store for EU canada and uplisting from OTC pinks to Nasdaq tier....??? GL fingers crossed!
Beech
Comment by
oakey123 on Aug 27, 2015 3:10pm
agree given the Huge institutional interest and patten protection till 2032 gonna be very exciting days ahead
Comment by
cheetio on Aug 27, 2015 3:17pm
Will be disappointing .......rubbish.....fcked Standard review designation is assigned to applications for drugs that do not meet the priority review designation criteria.